A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

Resources Index

CAS Launches Innovation Incubator to Partner with Early-stage Innovators
Through the CAS Innovation Incubator, CAS offers resources, expertise, and potential funding to early-stage innovators to help boost their science-based ventures.

Case Study: Data quality impact on algorithmic prediction of biological activity
AI and machine learning are showing great promise for enhancing research productivity in many disciplines. However, there are still many well-documented challenges for implementing these technologies in R&D applications and many opportunities to build on the efforts to date for greater success. In fact, one Gartner analyst estimated that as many as 85% of AI-driven projects are not meeting their objectives. As I had posted about previously, I, and many others, believe that one of the primary gaps often impacting these success rates is data quality.

Tips to avoid patent pitfalls as market for RNAi-derived therapeutics grows
The value and complexity of the patent landscape around RNA interference (RNAi) is increasing, creating special challenges for patent searches to protect IP and maximize its value. Learn how CAS can help with an IP search on RNAi or other emerging technology areas.

Why the Omicron BA.5 Variant Evades Vaccines
As COVID-19 cases rise again worldwide, the Omicron subvariant BA.5 is currently the dominant strain. This blog explores some key mutations that increase transmission, evade protective antibodies, and increase the rate of (re)infection.

Taking aim at COVID-19’s most wanted targets
In support of ongoing research efforts to identify additional drugs for COVID-19, a team of CAS scientists analyzed published scientific information and created a comprehensive report focusing on proteins involved in COVID-19 and potential corresponding drug candidates. Learn how CAS has committed to leveraging their assets and capabilities to support the fight against COVID-19.

Global Science & Technology Trends Report: Gene and Cell Therapy R&D
This CAS white paper identifies major trends in gene and cell therapy R&D that may help to predict future developments and pinpoint opportunities for therapeutic applications in the treatment of various diseases.

CAS to collaborate with MIT on research to enhance predictive chemical synthesis planning
CAS collaborated with MIT to accelerate research on chemical synthesis planning. CAS will provide MIT with scientist-curated data for AI training.

CAS Partnership with INPI Brazil Demonstrates AI Success in Increasing Examiner Productivity
A new artificial intelligence-enabled solution from CAS transforms patent offices by halving examination times and reducing patent backlogs.

Mana.bio integrates CAS chemical substance data into its novel drug delivery AI platform
CAS is launching a collaboration with Mana.bio to enrich their proprietary database to fuel its AI engine, with an expected 70% reduction in resources allocated to molecular data acquisition and preparation.